Literature DB >> 2809958

Definitive treatment of focal nodular hyperplasia of the liver by ethanol embolization.

P Soucy1, P Rasuli, S Chou, B Carpenter.   

Abstract

Focal nodular hyperplasia (FNH) is a benign, usually asymptomatic liver tumor with no predisposition to spontaneous hemorrhage. Treatment is not mandatory unless large size, compression symptoms, or fear of traumatic hemorrhage indicate otherwise. Ethanol embolotherapy offers a safe and effective alternative to surgery. FNH lends itself particularly well to embolotherapy because it is usually fed by a single end-artery with no intratumoral arteriovenous shunting or parasitic blood supply. An illustrative case is presented. Diagnosis was established by ultrasound, computed tomography (CT) scan, radionuclide scan, and arteriography and was confirmed by biopsy. Ethanol embolization resulted in shrinkage of a 10 x 14 cm tumor to a 1.5-cm calcified nodule over an 18-month period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809958     DOI: 10.1016/s0022-3468(89)80226-x

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Transarterial embolization as a therapeutic option for focal nodular hyperplasia in four patients.

Authors:  Thomas J Vogl; Ahmed Own; Renate Hammerstingl; Petra Reichel; Jörn O Balzer
Journal:  Eur Radiol       Date:  2005-08-20       Impact factor: 5.315

2.  Focal nodular hyperplasia of the liver: results of treatment and options in management.

Authors:  J A Pain; A E Gimson; R Williams; E R Howard
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

3.  Transarterial embolization with bleomycin for symptomatic hepatic focal nodular hyperplasia.

Authors:  Guodong Zhang; Maoqiang Wang; Feng Duan; Kai Yuan; Kai Li; Jieyu Yan; Zhongfei Chang
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.